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Abstract
Background: Alterations of endocannabinoid system in adipose tissue play an important role in lipid regulation
and metabolic dysfunction associated with obesity. The purpose of this study was to determine whether gene
expression levels of cannabinoid type 1 receptor (CB1) and fatty acid amide hydrolase (FAAH) are different in
subcutaneous abdominal and gluteal adipose tissue, and whether hypocaloric diet and aerobic exercise influence
subcutaneous adipose tissue CB1 and FAAH gene expression in obese women.
Methods: Thirty overweight or obese, middle-aged women (BMI = 34.3 ± 0.8 kg/m
2, age = 59 ± 1 years)
underwent one of three 20-week weight loss interventions: caloric restriction only (CR, N = 9), caloric restriction
plus moderate-intensity aerobic exercise (CRM, 45-50% HRR, N = 13), or caloric restriction plus vigorous-intensity
aerobic exercise (CRV, 70-75% HRR, N = 8). Subcutaneous abdominal and gluteal adipose tissue samples were
collected before and after the interventions to measure CB1 and FAAH gene expression.
Results: At baseline, FAAH gene expression was higher in abdominal, compared to gluteal adipose tissue (2.08 ±
0.11 vs. 1.78 ± 0.10, expressed as target gene/b-actin mRNA ratio × 10
-3, P < 0.05). Compared to pre-intervention,
CR did not change abdominal, but decreased gluteal CB1 (Δ = -0.82 ± 0.25, P < 0.05) and FAAH (Δ = -0.49 ± 0.14,
P < 0.05) gene expression. CRM or CRV alone did not change adipose tissue CB1 and FAAH gene expression.
However, combined CRM and CRV (CRM+CRV) decreased abdominal adipose tissue FAAH gene expression (Δ =
-0.37 ± 0.18, P < 0.05). The changes in gluteal CB1 and abdominal FAAH gene expression levels in the CR alone
and the CRM+CRV group were different (P < 0.05) or tended to be different (P = 0.10).
Conclusions: There are depot differences in subcutaneous adipose tissue endocannabinoid system gene
expression in obese individuals. Aerobic exercise training may preferentially modulate abdominal adipose tissue
endocannabinoid-related gene expression during dietary weight loss.
Trial Registration: ClinicalTrials.gov: NCT00664729.
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Background
Obesity is a risk factor for the development of type 2
diabetes and cardiovascular disease [1,2]. Endocannabi-
noids, which are derived from membrane phospholipids
(anandamide [AEA]) and triglycerides (2-arachidonoyl-
glycerol [2-AG]), increase food intake and weight gain
by activating central endocannabinoid receptors [3,4].
With obesity, endocannabinoid dysregulation occurs in
peripheral sites, linking the enlarged adipose tissue and
metabolic dysfunction [4-7].
In rodents, endocannabinoids bind to G-protein-coupled
cannabinoid type-1 (CB1) and cannabinoid type-2 (CB2)
receptors. CB1 receptors are mainly expressed in the
brain, digestive organs and adipose tissue, whereas CB2
receptors are mainly expressed in immune cells [8]. Endo-
cannabinoids are degraded by the key enzyme fatty acid
amide hydrolase (FAAH) in these tissue/cells [9]. In over-
weight and obese subjects, depot differences in adipose
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pared in several studies. Some [10,11], but not all [12] stu-
dies, support that adipose tissue gene expression levels of
CB1 and FAAH are higher in visceral than in abdominal
subcutaneous fat. However, it is important to study if gene
expression of these important components of the endo-
cannabinoid system are different between abdominal and
gluteal subcutaneous fat tissue.
Current studies indicate that weight loss by 5% does not
change adipose tissue gene expression levels of CB1 and
FAAH in abdominal subcutaneous adipose tissue [7,13].
However, it is not known if substantial weight loss (> 10%)
by diet and exercise could change gene expression of CB1
and FAAH in adipose tissue. Moreover, although acute exer-
cise activates the endocannabinoid system [14], the effect of
aerobic exercise training on endocannabinoid-related gene
expression in adipose tissue is yet to be investigated.
Thus, we tested the hypothesis that there is depot dif-
ference in subcutaneous adipose tissue CB1 and FAAH
gene expression, and caloric restriction and aerobic
exercise training alter subcutaneous adipose tissue CB1
and FAAH gene expression in obese older women.
Methods
Subjects
All women were recruited according to the following
inclusion/exclusion criteria: 1) overweight or obese
(BMI = 25-40 kg/m
2 and waist girth > 88 cm), 2) older
(age = 50-70 yrs, and at least one year without menses),
3) non-smoking, 4) not on hormone replacement ther-
apy, 5) sedentary (< 15 min of exercise, 2 times/wk) in
the past 6 months, and 6) weight-stable (< 5% weight
change) for at least 6 months prior to enrollment. The
study was approved by the Wake Forest University Insti-
tutional Review Board for Human Research. All women
signed informed consent to participate in the study.
Women with evidence of untreated hypertension
(blood pressure > 160/90 mmHg), hypertriglyceridemia
(triglycerides > 400 mg/dl), insulin-dependent diabetes,
active cancer, liver, renal or hematological disease were
excluded after an initial screening included a medical
history review, physical examination, fasting blood pro-
file (lipoprotein lipids and glucose) and 12-lead resting
electrocardiogram. In addition, all subjects underwent a
graded treadmill exercise test to exclude those with an
abnormal cardiovascular response to exercise [15]. All
women were randomly assigned to either a caloric
restriction alone (CR), CR plus moderate-intensity exer-
cise (CRM), or CR plus vigorous-intensity exercise
(CRV) intervention for a period of 20 weeks.
Study design
This study was part of the Diet, Exercise, and Metabo-
lism for Older Women Study, a randomized completed
from 2003 to 2007 [16-19]). Baseline measurements of
body composition, maximal aerobic capacity (VO2max),
and adipose tissue CB1 and FAAH gene expression
were performed after at least 2 weeks of weight stability
before the interventions. Body composition and
VO2max were measured on the same day. Fat biopsies
were performed in a morning after an over-night fast,
and at least 5 days after the VO2max test. The women
were retested in the same manner after the 20-week
interventions. The post-intervention fat biopsies
occurred at least 2 days after the last exercise session.
Study interventions
During the 20-week interventions, all women were pro-
vided food for their lunch and supper, which was pre-
pared by the Wake Forest University General Clinical
Research Center (GCRC) metabolic kitchen staff. These
meals were prepared individually after women chose
from a hypocaloric menu designed by a registered dieti-
tian (RD). Women purchased and prepared their break-
fast meal, in consultation with the RD. They were
allowed 2 free days per month, during which they were
given guidelines for diet intake and asked to report all
i n t a k e .T h e yw e r ea l s oa l l o w e dt oc o n s u m ea sm a n y
non-caloric, non-caffeinated beverages as they liked. In
addition, all women were provided with a daily calcium
supplement (1000 mg/day).
The diet only group was asked not to alter their physi-
cal activity habits during the study. Both diet plus exer-
cise groups walked on a treadmill three days/week at a
target heart rate calculated from the Karvonen equation
[(HRR × (intensity)+ resting heart rate] [20], where
heart rate reserve (HRR) is maximal heart rate minus
resting heart rate obtained from each subject’sV O 2max
test. The duration and intensity of the exercise pro-
gressed from 15-20 min at 45-50% of HRR during the
first week to 55 min at 45-50% HRR for the moderate-
intensity group, and 30 min at 70-75% HRR for the vig-
orous-intensity group by the second month. The calorie
deficits of all women were adjusted to ~2800 kcal/week.
The deficits for the diet only group resulted totally from
reduction in dietary intake, whereas deficits for the diet
plus exerciser groups result e df r o mb o t hr e d u c t i o n si n
dietary intake (~2400 kcal/week) and in exercise expen-
diture (~400 kcal/week). The average daily calorie intake
recorded by all women was 100.3 ± 0.2% of the provided
calorie level. The exercise compliance (attendance at
scheduled sessions) was 81.0 ± 8.9% for the moderate-
intensity exercise group, and 85.4 ± 9.3% for the vigor-
ous-intensity exercise group.
Body composition
Height and weight of each woman were measured to
calculate BMI (kg/m
2). Waist (minimal circumference)
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and percent body fat were measured by dual energy X-
ray absorptiometry (Hologic Delphi QDR, Bedford, MA).
Maximal aerobic capacity
VO2max was measured on a motor-driven treadmill
(Medical Graphics Corporation, Minneapolis, MN) dur-
ing a graded exercise test. A ramp treadmill protocol
was used. Each test was set for a duration of 12 minutes
with a goal of 12 metabolic equivalents, and the tread-
mill self-adjusted the incline to reach that goal. A valid
VO2max was obtained when a respiratory exchange
ratio (RER) of 1.10 had been reached. If the participant
did not reach this criterion, the test was repeated.
Adipose tissue gene expression
Subcutaneous abdominal and gluteal adipose tissue was
t a k e nb ya s p i r a t i o nw i t ha1 6 - g a u g en e e d l eu n d e rl o c a l
anesthesia (2% xylocaine) after an overnight fast. The
samples were put in warm saline and transported imme-
diately to the laboratory where they were washed twice
with saline to eliminate blood and other connective tis-
sue. Immediately after the washing, approximately 0.5 g
of tissue was snap frozen in liquid nitrogen and then
stored at -80°C for later isolation of total RNA for CB1,
FAAH, IL-6 and TNF-a gene expression.
Total RNA was isolated from frozen adipose tissue
samples with the RNeasy lipid tissue kit (Qiagen, Valen-
cia, CA). The isolated total RNA was quantified by mea-
surement of absorbency at 260 and 280 nm, and its
integrity was verified using agarose gels (1%) stained
with ethidium bromide. Total RNA samples were stored
at -80°C until measurement of gene expression.
CB1, FAAH, IL-6 and TNF-a mRNA expression
levels were measured by real-time RT-PCR. First, 1 μg
of total RNA was used for the reverse transcription
reaction to synthesize the first-strand cDNA, using the
random hexamer primers and following the instruc-
tions of the Advantage RT-for-PCR Kit (Clontech, Palo
Alto, CA). Real-time quantification of target gene
(CB1, FAAH, IL-6 and TNF-a)t ob-actin mRNA was
performed, using ABI Taqman PCR kits on an ABI
PRISM 7900 Sequence Detection System (Applied Bio-
systems, Foster City, CA ) .C B 1 ,F A A H ,I L - 6 ,T N F - a
and b-actin mRNA were amplified in different wells
and in duplicates, and the increase in fluorescence was
measured in real time. Data were obtained as threshold
cycle (CT) values. Relative gene expression was calcu-
lated using the formula (1/2)
CT Target Gene-CT b-actin.
Statistical analyses
Statistical analyses were performed using IBM SPSS Statis-
tics 19 (Armonk, NY). First, general characteristics of study
participants were compared using one-way ANOVA (for
continuous variables) or the Chi-square test (for categorical
variables). Differences in body composition, aerobic fitness,
and metabolic variables among the intervention groups
(CR, CRM and CRV) at baseline and over-time changes in
response to the interventions were determined using one-
way ANOVA.T h eL S Dpost-hoc test was used to determine
any group differences if an overall group effect was ascer-
tained. Depot (gluteal and abdominal) differences in adi-
pose tissue gene expression at baseline in the whole cohort,
and the within-group differences between pre-intervention
and post-intervention measures of all variables were deter-
mined using a paired t-test. Differences in CB1, FAAH, IL-
6a n dT N F - a gene expression among the intervention
groups (CR, CRM and CRV) at baseline and over-time
changes were determined using one-way ANOVA.T h e
LSD post-hoc test was used for identifying any group differ-
ences. The differences in CB1 and FAAH gene expression
between the diet alone (CR) and combined diet plus exer-
cise groups (CRM+CRV) were also determined by using a
paired t-test. Correlations between CB1 or FAAH and cyto-
kines were determined by using Pearson parametric or
Spearman nonparametric analysis. All data are presented as
mean ± standard error, and the level of significance was set
at P < 0.05 for all analyses.
Results
Subject characteristics
Thirty women (CR: N = 9; CRM: N = 13; CRV: N = 8)
completed the intervention and had sufficient adipose tissue
sample amounts for analysis on both fat depots. General
characteristics of these 30 women are shown in Table 1 by
intervention group. There were no group differences in age,
years post-menopause, or percent of African Americans.
Effects of caloric restriction alone, caloric restriction plus
moderate-intensity exercise, and caloric restriction plus
vigorous-intensity exercise on body composition, aerobic
fitness, and metabolic variables
Body composition and aerobic fitness measures before
and after the interventions in all 3 groups are shown in
Table 2. At baseline, there were no group differences in
body weight, fat mass, percent body fat, waist, maximal
aerobic capacity (absolute and relative VO2max), and
Table 1 General characteristics of the study participants.
CR (n = 9) CRM (n = 13) CRV (n = 8)
Age (yrs) 59 ± 2 57 ± 2 62 ± 2
Post-menopause (yrs) 15 ± 2 11 ± 3 20 ± 6
African American (%) 11.1 30.8 12.5
Mean ± SE or %. General characteristics of study participants were compared
using one-way ANOVA (for continuous variables) or the Chi-square test (for
categorical variables). CR: caloric restriction only; CRM: caloric restriction plus
moderate-intensity aerobic exercise; CRV: caloric restriction plus vigorous-
intensity aerobic exercise.
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higher insulin levels in CRV compared to CR and CRM
groups (both P < 0.01). All three interventions reduced
body weight, fat mass, percent body fat, and waist (all P
< 0.01). All three interventions did not change absolute
VO2max; however, CRM and CRV, but not CR alone,
increased relative VO2max (both P < 0.01). While only
CRV reduced fasting glucose levels (P < 0.05), all three
interventions decreased fasting insulin (P < 0.05 to P <
0.01). All three groups lost a similar amount of body
weight (CR: -11.1 ± 1.3%; CRM: -13.3 ± 0.9%; CRV:
-13.8 ± 1.6%). Compared to CR alone, CRV resulted in
more reductions in fat mass, percent body fat, fasting
insulin and HOMA index (all P < 0.05). There were no
differences in reductions in waist circumference, maxi-
mal aerobic capacity and fasting glucose in all three
groups.
Effects of caloric restriction alone, caloric restriction plus
moderate-intensity exercise, and caloric restriction plus
vigorous-intensity exercise on adipose tissue
endocannabinoid system gene expression
At baseline, FAAH gene expression was higher in sub-
cutaneous abdominal, compared to gluteal adipose tissue
(P < 0.05), whereas there was no depot difference in adi-
pose tissue CB1 gene expression (Figure 1).
A d i p o s et i s s u eC B 1a n dF A A Hg e n ee x p r e s s i o nl e v e l s
before and after the interventions in all 3 groups are
shown in Table 3. At baseline, there were no group dif-
ferences in adipose tissue CB1 and FAAH mRNA levels.
Compared to pre-intervention, CR alone did not change
abdominal, but decreased gluteal CB1 and FAAH gene
expression (both P < 0.05). CRM or CRV alone did not
change abdominal and gluteal adipose tissue CB1 and
FAAH gene expression.
However, combined CRM and CRV groups decreased
abdominal adipose tissue FAAH gene expression (P <
0.05). CRM+CRV did not change gluteal adipose tissue
FAAH gene expression, or gluteal and abdominal adi-
pose tissue CB1 gene expression.
The changes in gluteal adipose tissue CB1 gene expres-
sion levels in the CR alone group were different from
those in the CRM+CRV groups (P < 0.05), whereas there
was no group difference in gluteal adipose tissue FAAH
gene expression (Figure 2). The changes in abdominal adi-
pose tissue FAAH gene expression levels in the CRM
+CRV groups tended to be different from those in the CR
group (P = 0.10), whereas there was no group difference in
abdominal adipose tissue CB1 gene expression (Figure 3).
Effects of caloric restriction alone, caloric restriction plus
moderate-intensity exercise, and caloric restriction plus
vigorous-intensity exercise on adipose tissue cytokine
gene expression
At baseline, IL-6 gene expression was higher in subcuta-
neous gluteal, compared to abdominal adipose tissue
Table 2 Body composition, maximal aerobic capacity, and metabolic variables before and after interventions.
CR (n = 9) CRM (n = 13) CRV (n = 8)
Pre Post Pre Post Pre Post
Weight (kg) 86.8 ± 3.6 75.7 ± 3.8
† 93.8 ± 2.9 80.5 ± 2.6
† 92.4 ± 5.5 78.5 ± 4.7
†
Fat mass (kg) 37.3 ± 2.4 30.2 ± 2.8
† 42.3 ± 1.5 32.8 ± 1.2
† 43.0 ± 3.1 31.6 ± 2.6
†
Percent fat (%) 41.7 ± 1.1 38.6 ± 1.7
† 44.1 ± 0.9 40.0 ± 0.9
† 45.0 ± 0.8 39.2 ± 1.2
†
Waist (cm) 95 ± 3 86 ± 3
† 98 ± 2 87 ± 2
† 100 ± 3 89 ± 3
†
Absolute VO2max (l/min) 1.87 ± 0.09 1.82 ± 0.12 1.96 ± 0.08 1.97 ± 0.07 1.90 ± 0.19 2.16 ± 0.14
Relative VO2max (ml/min/kg) 21.6 ± 0.8 23.6 ± 1.4 21.5 ± 1.0 24.2 ± 0.8* 20.3 ± 1.4 26.2 ± 1.0*
Glucose (mg/dl) 95.4 ± 2.9 90.7 ± 1.4 94.0 ± 2.4 90.2 ± 2.0 102.1 ± 6.9 91.3 ± 3.6*
Insulin (pmol/l) 91.5 ± 12.1 70.2 ± 12.5* 66.4 ± 10.8 43.7 ± 6.7* 147 ± 26.1 83.5 ± 12.3
†
Mean ± SE. Body composition, maximal aerobic capacity, and metabolic variables were compared using paired tests. VO2max: maximal aerobic capacity; HOMA:
homeostatic model assessment. *P < 0.05,
† P < 0.01 compared with baseline.
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Figure 1 Depot differences in adipose tissue CB1 and FAAH gene
expression (mean ± SE, n = 30). Gene expression levels of CB1 and
FAAH between gluteal and abdominal adipose tissue depots were
compared using paired tests. *P < 0.05 compared to Gluteal.
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Page 4 of 8(4.35 ± 0.57 vs. 1.96 ± 0.28, expressed as target gene/b-
actin mRNA ratio × 10
-2, P < 0.01), whereas there was
no depot difference in adipose tissue TNF-a gene
expression.
Adipose tissue IL-6 and TNF-a gene expression levels
before and after the interventions in all 3 groups are
shown in Table 4. At baseline, there were no group dif-
ferences in adipose tissue IL-6 and TNF-a mRNA levels.
Compared to pre-intervention, CR, CRM or CRV alone
did not change abdominal and gluteal adipose tissue IL-
6a n dT N F - a gene expression. However, in the whole
cohort, combined diet and exercise interventions signifi-
cantly reduced gluteal adipo s et i s s u eg e n ee x p r e s s i o n
levels of IL-6 (from 4.35 ± 0.57 to 2.50 ± 0.40, P < 0.05)
and TNF-a (from 4.75 ± 1.16 to 2.58 ± 0.44, P < 0.05).
Relationship of adipose tissue endocannabinoid system
gene expression to cytokine gene expression after diet
and exercise interventions
In the whole cohort, change in abdominal CB1 gene
expression tended to be related to change in abdominal
IL-6 gene expression (r = 0.33, P = 0.07), and change in
gluteal FAAH gene expression tended to be related to
change in gluteal TNF-gene expression (r = 0.31, P =
0.09). No other significant relationships were found
between changes in local adipose tissue CB1 or FAAH
and cytokine gene expression levels.
Discussion
This study investigated whether there was a depot dif-
ference in abdominal and gluteal subcutaneous adipose
tissue gene expression of two important components of
Table 3 Adipose tissue CB1 and FAAH gene expression before and after interventions.
CR (n = 9) CRM (n = 13) CRV (n = 8)
Pre Post Pre Post Pre Post
CB1/b-actin mRNA ratio (× 10
-3)
Abdominal 4.22 ± 0.78 5.40 ± 0.10 3.94 ± 0.36 3.71 ± 0.29 4.59 ± 0.56 4.41 ± 0.69
Gluteal 4.84 ± 0.55 4.02 ± 0.66* 3.74 ± 0.28 3.99 ± 0.42 4.43 ± 0.86 4.83 ± 0.72
FAAH/b-actin mRNA ratio (× 10
-3)
Abdominal 1.86 ± 0.20 2.05 ± 0.24 2.32 ± 0.19 1.94 ± 0.16 1.93 ± 0.15 1.59 ± 0.17
Gluteal 1.82 ± 0.21 1.33 ± 0.19* 1.86 ± 0.15 1.70 ± 0.14 1.60 ± 0.17 1.36 ± 0.13
Mean ± SE. Gene expression levels were compared using paired tests. *P < 0.05 compared with baseline.
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Figure 2 Effects of caloric restriction and caloric restriction
plus exercise on gluteal adipose tissue CB1 and FAAH gene
expression (mean ± SE, CR: n = 9; CRM+CRV: n = 21). Changes
in gene expression levels of CB1 and FAAH between gluteal and
abdominal adipose tissue depots were compared between caloric
restriction and caloric restriction plus aerobic exercise using paired
tests. *P < 0.05 compared to CR.
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Figure 3 Effects of caloric restriction and caloric restriction
plus exercise on abdominal adipose tissue CB1 and FAAH
gene expression (mean ± SE, CR: n = 9; CRM+CRV: n = 21).
Changes in gene expression levels of CB1 and FAAH between
gluteal and abdominal adipose tissue depots were compared
between caloric restriction and caloric restriction plus aerobic
exercise using paired tests.
‡ P = 0.10 compared to CR.
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whether caloric restriction alone, and caloric restriction
plus aerobic exercise differentially influenced adipose
tissue CB1 and FAAH gene expression in obese older
women. Our findings showed that compared to gluteal
adipose tissue, abdominal adipose tissue had higher
FAAH gene expression. Caloric restriction alone low-
ered gluteal CB1 and FAAH gene expression, whereas
caloric restriction plus aerobic exercise reduced abdom-
inal adipose tissue FAAH gene expression.
Previous studies indicate that circulating levels of
endocannabinoids are elevated in obesity, possibly
reflecting a partial overflow from the tissues that pro-
duce and release endocannabinoids [21]. Adipose tissue
expresses all the essential components of the endocan-
nabinoid system, therefore is possible the main organ
that contributes to the elevated circulating endocannabi-
noid levels and metabolic dysfunctions [22]. The
increased adipose tissue endocannabinoid levels could
be due to an increased production and/or a decreased
degradation. Several human studies reported that CB1
and FAAH gene expression in visceral and subcutaneous
adipose tissue were decreased with obesity and the
expression levels were negatively related to visceral fat-
ness [7,10,23]. However, other studies reported no
changes in CB1 gene expression in visceral and subcuta-
neous adipose tissue [12], or even elevated CB1 and
FAAH gene expression in visceral and subcutaneous
adipose tissue with obesity [24,25]. Two recent studies
indicated that CB1 gene expression in visceral adipose
tissue was positively related to visceral fat mass in
obese-hypertensive patients [26], and FAAH activity in
subcutaneous adipose tissue correlated positively to BMI
in healthy adults [27]. All these studies were cross-sec-
tional comparison studies.
Several previous human studies compared the depot
differences in adipose tissue CB1 and FAAH gene
expression. Interestingly, some studies indicate that visc-
eral adipose tissue expresses higher levels of CB1 and
FAAH than subcutaneous adipose tissue in obese indivi-
duals [10,11]. In one study, although obese subjects had
lower expression of CB1 and FAAH in both
subcutaneous and visceral adipose tissue than lean sub-
jects, CB1 and FAAH expression levels in visceral adi-
pose tissue are higher than those in subcutaneous
adipose tissue in all three groups, including lean, subcu-
taneous obese and visceral obese individuals [10]. A
recent study reported that there were depot differences
in subcutaneous adipose tissue CB1 gene expression
levels in obese individuals [28]. Here, our findings sup-
port that there are depot differences in upper and lower
body subcutaneous adipose tissue FAAH gene expres-
sion in obese women. The differences in FAAH expres-
sion among different adipose tissue depots could be due
to the differences in endocannabinoid levels in these
depots, which are influenced by adipose tissue inflam-
matory cytokines.
There are limited data regarding the effects of weigh
loss and/or exercise training on adipose tissue endocan-
nabinoid system in obesity. In two previous studies,
weight loss by 5% did not change abdominal adipose tis-
sue CB1 and FAAH gene expression [7,13]. Weight loss
also did not influence circulating levels of endocannabi-
noids [7,13]. In a recent study, dietary weight loss by
10-12% altered subcutaneous adipose tissue 2-AG levels
and lowered CB1 and FAAH gene expression levels in
gluteal, but not abdominal adipose tissue [28]. The pos-
sible reason for the mixed results could be the differ-
ences in the amounts of weight loss in these studies. In
an animal study, high-fat feeding significantly increased
visceral and subcutaneous adipose tissue CB1 protein
expression and exercise training inhibited this high-fat
feeding related effects on adipose tissue CB1 protein
expression [29]. However, there were no human studies
regarding the effects of exercise training on adipose tis-
sue endocannabinoid system.
In the current study, we observed that caloric restric-
tion lowered gluteal adipose tissue CB1 and FAAH gene
expression. These results support the findings of another
study [28] and may indicate that weight loss by more
than 10% may alter adipose tissue endocannabinoid-
related gene expression. Moreover, caloric restriction
plus exercise training, including moderate- and vigor-
ous-intensity aerobic exercise, lowered abdominal
Table 4 Adipose tissue IL-6 and TNF-a gene expression before and after interventions.
CR (n = 9) CRM (n = 13) CRV (n = 8)
Pre Post Pre Post Pre Post
IL-6/b-actin mRNA ratio (× 10
-2)
Abdominal 2.37 ± 0.66 1.47 ± 0.50 1.65 ± 0.32 2.09 ± 0.78 2.15 ± 0.44 2.20 ± 0.80
Gluteal 4.29 ± 0.83 1.75 ± 0.69 4.87 ± 1.00 2.66 ± 0.31 3.63 ± 1.19 2.92 ± 1.12
TNF-a/b-actin mRNA ratio (× 10
-2)
Abdominal 4.46 ± 2.20 3.09 ± 1.22 3.62 ± 1.55 2.12 ± 0.39 4.11 ± 2.37 2.48 ± 0.69
Gluteal 5.19 ± 2.11 2.09 ± 0.51 5.63 ± 2.29 2.81 ± 0.55 2.90 ± 0.81 2.84 ± 1.35
Mean ± SE. Gene expression levels were compared using paired tests.
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Page 6 of 8adipose tissue FAAH gene expression. In a previous
study, abdominal adipose tissue FAAH gene expression
is positively related to hyerinsulinemia [25]. Moreover,
visceral adipose tissue endocannabinoid system activa-
tion was mediated by inflammatory cytokines in obesity
[23]. In the current study, changes in endocannabinoid
system gene expression tended to be related to changes
in IL-6 and TNF-a gene expression, indicating a possi-
ble link between endocannabinoid system and chronic
inflammation in obese individual under diet and exercise
interventions.
T h ef i n d i n g st h a ta b d o m i n a la d i p o s et i s s u ee x p r e s s e s
higher levels of FAAH than gluteal adipose tissue, and
caloric restriction and caloric restriction plus exercise
differentially influenced local adipose tissue endocanna-
binoid system are interesting. It is notable that circulat-
ing and adipose tissue levels of AEA and 2-AG were not
measured. Addition of these measures in future studies
will provide us with a clearer picture of the depot differ-
ences and intervention effects on adipose tissue endo-
cannabinoid system. One of the limitations of the
current study is that the sample size in each group was
relatively small. With bigger sample size, we would be
able to detect a significant exercise effect on abdominal
adipose tissue FAAH gene expression in obese indivi-
duals under caloric restriction.
Conclusions
Subcutaneous adipose tissue FAAH gene expression is
higher in abdominal fat depot than in gluteal fat depot;
caloric restriction alone altered gluteal adipose tissue
CB1 and FAAH gene expression, whereas caloric restric-
tion plus aerobic exercise changed abdominal adipose
tissue FAAH gene expression. These effects may be of
importance for the metabolic properties of local adipose
tissue and the effects of diet and exercise interventions
on adipose tissue metabolic function. Since the studies
on adipose tissue endocannabinoid system are on the
early stages and mixed findings exist in these studies,
further investigations need to focus on the relationship
of the components of this system to local and system
metabolic risk factors in future cross-sectional or inter-
vention studies.
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